Juan Valle, Chief Medical Officer at Cholangiocarcinoma Foundation, posted on LinkedIn:
“It is a pleasure to be representing the Cholangiocarcinoma Foundation at the inaugural Cholangiocarcinoma Foundation Meeting Brazil, an important event advancing personalized medicine for bile duct cancer.
This meeting is bringing together international leaders in precision medicine, gastrointestinal cancer, and cholangiocarcinoma. We are engaging in deep clinical case discussions and exploring cutting-edge genomic labs, cellular and gene therapy research, and centers of excellence in robotic surgery, nuclear medicine, and interventional radiology.”
Read more posts featuring Juan Valle at OncoDaily.com.